These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2674462)

  • 1. Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.
    Edmonson JH; Long HJ; Jeffries JA; Buckner JC; Colon-Otero G; Fitch TR
    J Natl Cancer Inst; 1989 Oct; 81(19):1510-2. PubMed ID: 2674462
    [No Abstract]   [Full Text] [Related]  

  • 2. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
    Yamashita J; Kawamura T; Shoin K
    No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
    Gianni AM; Bregni M; Siena S; Orazi A; Stern AC; Gandola L; Bonadonna G
    J Clin Oncol; 1990 May; 8(5):768-78. PubMed ID: 2185337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?
    Demetri GD; Griffin JD
    J Clin Oncol; 1990 May; 8(5):761-4. PubMed ID: 1692086
    [No Abstract]   [Full Text] [Related]  

  • 6. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
    Cortes-Funes H
    Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF: intravenous versus subcutaneous treatment.
    Aglietta M; Monzeglio C; Piacibello W; Aprá F; Stacchini A; Sanavio F; Mossetti C; Stern AC; Gavosto F
    Leukemia; 1990 Jul; 4(7):523. PubMed ID: 2197516
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
    Steward WP; Scarffe JH; Bonnem E; Crowther D
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():335-46. PubMed ID: 2182743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS file. GM-CSF may boost WBC counts.
    Conover AC
    Am J Nurs; 1990 Apr; 90(4):29. PubMed ID: 2181877
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant GM-CSF in myelosuppression of chemotherapy.
    N Engl J Med; 1989 Jan; 320(4):253-4. PubMed ID: 2643049
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human GM-CSF in myelosuppression of chemotherapy (continued).
    Bar MH; Aronson FR
    N Engl J Med; 1989 Apr; 320(14):939-40. PubMed ID: 2648149
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
    Bonnem EM; Morstyn G
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):46-51. PubMed ID: 3057644
    [No Abstract]   [Full Text] [Related]  

  • 14. GM-CSF with ganciclovir for the treatment of CMV retinitis in AIDS.
    Grossberg HS; Bonnem EM; Buhles WC
    N Engl J Med; 1989 Jun; 320(23):1560. PubMed ID: 2542793
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.
    Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H
    Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GM-CSF: its clinical administration; the treatment of aplasia].
    Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
    Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
    [No Abstract]   [Full Text] [Related]  

  • 17. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A
    Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
    Bregni M; Siena S; Ravagnani F; Bonadonna G; Gianni AM
    Haematologica; 1990; 75 Suppl 1():95-8. PubMed ID: 2190885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
    Shea TC; Mason JR; Storniolo AM; Newton B; Breslin M; Mullen M; Ward DM; Miller L; Christian M; Taetle R
    J Clin Oncol; 1992 Mar; 10(3):464-73. PubMed ID: 1740685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.